Where Canadian Federal Party Leaders Stand on Cannabis

Canada settled the cannabis question on October 17, 2018. The United States, our largest trading partner and closest cultural neighbour, is still working it out — and that asymmetry matters more than most Canadian growers realise. What happens south of the 49th parallel shapes cross-border seed policy, research funding, banking access for North American cannabis businesses, and the long-term regulatory environment we all operate within. So while Canadians can grow their four plants per household under the Cannabis Act without a second thought, understanding where U.S. federal policy has been, and where it's heading, remains genuinely useful intelligence for anyone serious about this plant.

A Country That Cannot Agree With Itself

Picture the American cannabis map. It is not a pretty picture of coherent policy.

The West Coast — Washington, Oregon, California, and effectively Nevada, moved early and hard on adult-use legalisation, building sophisticated regulatory frameworks with licensed dispensaries, tested products, and taxed supply chains. Directly inland, states like Idaho, Wyoming, and Montana remained firmly prohibitionist for years, with possession charges carrying sentences that would strike most Canadians as wildly disproportionate. Then there is Colorado, a landlocked state sitting in the middle of the continent, which launched the world's first regulated adult-use market in 2014 and never looked back.

The inconsistency is jarring. A gram of cannabis that is a perfectly legal consumer product in Denver becomes a criminal matter sixty kilometres east on Interstate 70 once you cross into Kansas. That patchwork of state-by-state rules, set against an unchanged federal Schedule I classification, is the backdrop against which every American politician must position themselves — and it is why the 2020 presidential field's cannabis positions were so politically revealing.

For Canadians, this fragmentation is a useful reminder of how rare and genuinely significant our own federal framework actually is. Our Legalisation under Bill C-45 was not inevitable — it required political will, years of public consultation, and a party willing to absorb the electoral risk. Understanding what that political journey looks like when it fails, or stalls, gives real depth to how we think about cannabis as both a plant and a policy matter.

The Big Names: Where Trump, Biden, and Sanders Stood

The 2020 U.S. presidential race produced a wide spectrum of cannabis positions, but three figures dominated the conversation: the incumbent, the eventual winner, and the progressive insurgent who pushed the Overton window further than anyone expected.

Donald Trump occupied an uncomfortable, contradictory position. In interviews, he had acknowledged cannabis could help people — "in some ways, I think it's good and in other ways, it's bad… I know people that have serious problems… and it really, really does help them", yet his administration's actions consistently cut against reform. Most pointedly, his White House blocked legislation that would have made it significantly easier to study the medical benefits of cannabis for military veterans. Actions, as the saying goes, speak louder than carefully hedged quotes. On federal legalisation, Trump was a firm no.

Joe Biden, meanwhile, surprised many progressive voters with a stance that felt several decades out of step. Despite running alongside Barack Obama — who publicly advocated treating cannabis as a public health issue, comparable to cigarettes and alcohol rather than a criminal matter, Biden held the gateway-drug line with conviction: "There's a difference between sending someone to jail for a few ounces and legalizing it… The punishment should fit the crime. But I think legalization is a mistake. I still believe it is a gateway drug." That position placed him in the same camp as Trump on the core federal question, a fact that frustrated large sections of the Democratic base.

Bernie Sanders occupied the opposite pole entirely. His framing was direct and unapologetic: "Right now, marijuana is listed by the federal government as a Schedule I drug — meaning that it is considered to be as dangerous as heroin. That is absurd." Sanders had been calling for federal descheduling for years before it became fashionable, and his 2020 campaign platform included not just legalisation but expungement of prior cannabis convictions and a federally regulated market, arguably the most comprehensive cannabis reform agenda of any major presidential candidate in U.S. history.

The contrast between Biden and Sanders on this single issue illustrated a generational and philosophical divide within the Democratic Party that cannabis, perhaps more than any other policy question, brought into sharp relief.

The Full Field: Who Was For, Who Was Against, Who Was Watching the Wind

The 2020 Democratic primary field was historically large, and cannabis served as an unexpectedly clear litmus test for where each candidate placed personal freedom, criminal justice reform, and public health in their political priorities.

Candidates Who Supported Federal Legalisation

The list in favour was long — and for anyone who had been watching U.S. cannabis politics evolve since the early Obama years, genuinely remarkable:

• Michael Bennet
• Cory Booker
• Pete Buttigieg
• Julián Castro
• Bill de Blasio
• Tulsi Gabbard
• Kirsten Gillibrand
• Kamala Harris
• John Hickenlooper
• Jay Inslee
• Seth Moulton
• Beto O'Rourke
• Tim Ryan
• Bernie Sanders
• Eric Swalwell
• Elizabeth Warren
• William Weld
• Marianne Williamson
• Andrew Yang

Nineteen candidates. In a race that also featured several fence-sitters — Amy Klobuchar, Wayne Messam, Steve Bullock, and John Delaney among them, only Trump and Biden held unambiguous anti-legalisation positions.

Pro vs. Anti: The Stark Contrast

The numbers told a clear story. On one side: nineteen declared supporters of federal legalisation, representing the majority of the primary field and the clear momentum of public opinion. On the other: two of the most powerful figures in the race, the incumbent president and the man who would ultimately beat him, both opposed to federal reform. This is the central tension of American cannabis politics — polling consistently shows majority public support for legalisation, yet the two men who faced each other in November 2020 both opposed it at the federal level. For Canadians watching from across the border, it was a vivid illustration of how slowly democratic systems absorb social change, even when the public has already moved on.

Why This Still Matters to Canadian Growers

It's tempting to shrug and say the American political circus has nothing to do with your grow tent in Kelowna or your backyard garden in Moncton. That would be a mistake.

U.S. federal cannabis policy shapes this continent in ways that touch Canadian cultivators directly. Banking and financial services for Canadian cannabis companies remain complicated partly because major institutions fear U.S. regulatory exposure. Seed genetics, cultivation research, and cross-border collaboration are all constrained by the ongoing federal Schedule I classification. The simple act of travelling to the U.S. while being employed in the Canadian cannabis industry — something Customs and Border Protection officers have asked about at the border, carries legal risk that would disappear with federal reform south of the border.

There is also the question of market scale. A federally legal United States would represent the largest regulated cannabis market on earth, with direct implications for Canadian producers, exporters, and the seed genetics market. The strains being developed and popularised in Canadian grow rooms today — dense, resin-heavy feminised varieties like The White, the legendary high-THC indica-leaning cultivar prized for its near-crystalline trichome coverage, are exactly the kind of genetics that a fully open North American market would elevate to iconic status.

The political and the horticultural are more connected than they appear.

Where the Conversation Goes From Here

The 2020 U.S. election did not deliver the federal cannabis reform that nineteen primary candidates had championed. Biden won the presidency maintaining his sceptical position, and while his administration eventually shifted toward supporting decriminalisation and rescheduling conversations, full federal legalisation remained unfinished business through his term. The U.S. Congress passed the SAFE Banking Act in various forms, and the DEA opened rescheduling review proceedings — incremental progress, but a far cry from the kind of clear federal framework that Canada established in 2018.

For Canadian cannabis cultivators, the practical takeaway is this:

1. Understand your competitive advantage. Years of operating under a clear federal framework have given Canadian growers, breeders, and seed producers a head start in building compliant, quality-focused operations that American producers are only now beginning to replicate at scale.
2. Watch U.S. federal rescheduling closely. A move from Schedule I to Schedule III — which the DEA has been actively reviewing — would be the single most significant regulatory event for the North American cannabis market since Canada's own legalisation, opening research funding, banking access, and interstate commerce possibilities that reshape the entire industry.
3. Keep growing excellent genetics. Policy catches up to culture eventually. The cultivars being refined in Canadian grow rooms right now are building the genetic foundation of a fully legalised continental market. That work matters regardless of what any politician says this election cycle.
4. Stay informed through trusted Canadian sources. The policy landscape shifts quickly, and understanding it helps you make smarter decisions about what to grow, when to invest, and how to think about the future of this plant.

Canada did not accidentally become a global leader in cannabis legalisation. It took clear policy, genuine political courage, and a cultivating community that had been building expertise for decades before Bill C-45 ever passed second reading. As the United States slowly, unevenly, and sometimes painfully works toward its own federal reckoning with cannabis, the Canadian advantage only deepens — for growers, for breeders, and for everyone who believes this plant deserves to be treated with the seriousness and respect it has long been due.

Grow well. The future belongs to the prepared.